Arcutis Biotherapeutics (ARQT) Moves 10.8% Higher: Will This Strength Last?

Arcutis Biotherapeutics, Inc. (ARQT) shares soared 10.8% in the last trading session to close at $16.60. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 11.8% gain over the past four weeks.The stock rallied after the company announced that Padagis had requested a stay to the ongoing patent litigation between Padagis and Arcutis. The companies agreed to stay the patent lawsuit related to Arcutis’ patented product Zoryve (roflumila ...